• Mashup Score: 1

    This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it.

    Tweet Tweets with this article
    • Abiraterone has helped to extend the lives of thousands of men like Alfred, Rob and Tony around the world. Read more about the discovery and development of abiraterone below (5/5). #ProstateCancerAwarenessMonth https://t.co/gkQTZ2MCa4

  • Mashup Score: 0

    This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it.

    Tweet Tweets with this article
    • 💊 Discovered by ICR scientists around 30 years ago, abiraterone has been available on the NHS for over a decade. This #ProstateCancerAwarenessMonth, we're looking back at how this drug became one of our greatest success stories⬇️ https://t.co/gkQTZ2MCa4 https://t.co/38a6y1DbKf

  • Mashup Score: 4

    The last decade has brought major advances in the way we diagnose and treat prostate cancer and men with advanced disease are living longer than ever. Diana Cano spoke to our scientists about the most exciting research areas that have the potential to revolutionise prostate cancer treatment in years to come.

    Tweet Tweets with this article
    • "There is no doubt that the most innovative years in prostate cancer research are yet to come." Read more about the most exciting areas of #ProstateCancer research that have the potential to revolutionise treatment 👇 #ProstateCancerAwarenessMonth https://t.co/c9EKhqeCOE

  • Mashup Score: 1
    Facebook - 2 year(s) ago

    Sidney Kimmel Cancer Center – Jefferson Health 2h Shared with PublicMihir Shah, MD, Clinical Assistant Professor, Department of Urology, answers some common questions about prostate cancer for #ProstateCancerAwarenessMonth.* What causes prostate cancer? What are the risk factors?There are a few risk factors that can place a man at risk for prostate cancer. These include age, ethnicity, and family…

    Tweet Tweets with this article
    • .@MihirShahMD, Clinical Assistant Professor, @JEFFUrology, answers some common questions about #ProstateCancer for #ProstateCancerAwarenessMonth: https://t.co/pxM8CnK3LH https://t.co/3E7FW9rYwz

  • Mashup Score: 1

    When the Urology team at Cleveland Clinic asked Jim Senary to be the first patient to trial a new surgical procedure to remove his prostate cancer, he said “yes” without thinking twice.

    Tweet Tweets with this article
    • For the first time, @drjkaouk and the surgical team used an epidural and “twilight” sedation, rather than intubated general anesthesia for Jim's robot-assisted prostatectomy. #prostatecancerawarenessmonth https://t.co/zGShIcL6Y1 https://t.co/jyOG83xJLc